| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6201097 | Ophthalmology | 2014 | 10 Pages |
Abstract
Persons at high risk for CNV developing benefit from the home monitoring strategy for earlier detection of CNV development, which increases the likelihood of better visual acuity results after intravitreal anti-VEGF therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
The AREDS2-HOME Study Research Group The AREDS2-HOME Study Research Group, Emily Y. (Writing Committee), Traci E. (Writing Committee), Susan B. (Writing Committee), Michael J. (Writing Committee), Ronald P. (Writing Committee),